399 related articles for article (PubMed ID: 35892653)
1. The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease.
Gordon J; Lockard G; Monsour M; Alayli A; Borlongan CV
Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892653
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke.
Alfieri A; Srivastava S; Siow RC; Modo M; Fraser PA; Mann GE
J Physiol; 2011 Sep; 589(17):4125-36. PubMed ID: 21646410
[TBL] [Abstract][Full Text] [Related]
3. The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
Kahroba H; Ramezani B; Maadi H; Sadeghi MR; Jaberie H; Ramezani F
Ageing Res Rev; 2021 Jan; 65():101211. PubMed ID: 33186670
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
5. Targeting NRF2 in Type 2 diabetes mellitus and depression: Efficacy of natural and synthetic compounds.
Subba R; Ahmad MH; Ghosh B; Mondal AC
Eur J Pharmacol; 2022 Jun; 925():174993. PubMed ID: 35513015
[TBL] [Abstract][Full Text] [Related]
6. Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.
Zhang R; Xu M; Wang Y; Xie F; Zhang G; Qin X
Mol Neurobiol; 2017 Oct; 54(8):6006-6017. PubMed ID: 27696223
[TBL] [Abstract][Full Text] [Related]
7. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
Sivandzade F; Bhalerao A; Cucullo L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336872
[TBL] [Abstract][Full Text] [Related]
9. Stem cells in stroke repair: current success and future prospects.
Gopurappilly R; Pal R; Mamidi MK; Dey S; Bhonde R; Das AK
CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):741-56. PubMed ID: 21838668
[TBL] [Abstract][Full Text] [Related]
10. Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2.
Liu L; Vollmer MK; Fernandez VM; Dweik Y; Kim H; Doré S
Front Cell Neurosci; 2018; 12():74. PubMed ID: 29628876
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of stem cell-based therapies for stroke.
Chrostek MR; Fellows EG; Crane AT; Grande AW; Low WC
Brain Res; 2019 Nov; 1722():146362. PubMed ID: 31381876
[TBL] [Abstract][Full Text] [Related]
12. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats.
Martín-Hernández D; Bris ÁG; MacDowell KS; García-Bueno B; Madrigal JL; Leza JC; Caso JR
Neuropharmacology; 2016 Apr; 103():79-91. PubMed ID: 26686388
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
15. Critical Role of Nrf2 in Experimental Ischemic Stroke.
Liu L; Locascio LM; Doré S
Front Pharmacol; 2019; 10():153. PubMed ID: 30890934
[TBL] [Abstract][Full Text] [Related]
16. Cell-based therapy for stroke.
Luo Y
J Neural Transm (Vienna); 2011 Jan; 118(1):61-74. PubMed ID: 20945074
[TBL] [Abstract][Full Text] [Related]
17. miR-214 protects erythroid cells against oxidative stress by targeting ATF4 and EZH2.
Gao M; Liu Y; Chen Y; Yin C; Chen JJ; Liu S
Free Radic Biol Med; 2016 Mar; 92():39-49. PubMed ID: 26791102
[TBL] [Abstract][Full Text] [Related]
18. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect.
Yang Y; Chen G; Cheng X; Teng Z; Cai X; Yang J; Sun X; Lu W; Wang X; Yao Y; Hu C; Cao P
Sci Rep; 2015 Jul; 5():12377. PubMed ID: 26205695
[TBL] [Abstract][Full Text] [Related]
20. Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy.
Ge ZD; Lian Q; Mao X; Xia Z
Int Heart J; 2019 May; 60(3):512-520. PubMed ID: 30971629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
